Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/01/2026 | 31/01/2025 |
|---|---|---|
| Revenue | 481M | 420M |
| Cost of revenue | 71M | 66M |
| Research and development | 121M | 117M |
| Selling, general and administrative | 80M | 77M |
| Operating expenses | 487M | 478M |
| Operating income | −7M | −58M |
| Pre-tax income | −9M | −56M |
| Income tax | −11M | 3M |
| Net income | 2M | −59M |
| Earnings per share | 0.04 | −1.02 |
| Earnings per share, diluted | 0.04 | −1.02 |
| Weighted average shares | 60M | 58M |
| Weighted average shares, diluted | 61M | 58M |
| Metric | 30/04/2026 | 31/01/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 76M | 74M | 106M | 98M | 91M | 84M | 82M | 82M |
| Receivables | 90M | 97M | 88M |
| Metric | 31/01/2026 | 31/01/2025 |
|---|---|---|
| Operating cash flow | 79M | 32M |
| Depreciation and amortisation | 31M | 28M |
| Share-based compensation | 67M | 67M |
| Capital expenditure | 11M | 9M |
| Investing cash flow | −162M | −24M |
| Financing cash flow | 73M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 77M |
| 75M |
| 74M |
| 71M |
| — |
| Current assets | 267M | 280M | 241M | 223M | 215M | 203M | 190M | — |
| Goodwill | 170M | 170M | 76M | 76M | 76M | 76M | 76M | — |
| Total assets | 666M | 664M | 423M | 409M | 400M | 388M | 376M | — |
| Current liabilities | 152M | 183M | 99M | 105M | 111M | 114M | 109M | — |
| Long-term debt | 85M | 92M | 3M | 5M | 6M | 8M | 10M | — |
| Total liabilities | 307M | 327M | 103M | 111M | 118M | 124M | 121M | — |
| Equity | 359M | 337M | 320M | 298M | 282M | 265M | 255M | 251M |
| Shares outstanding | — | 62M | 62M | 61M | 61M | 60M | 59M | — |
| Shares issued | 63M | 62M | 62M | 61M | 61M | 60M | 59M | — |
| Treasury shares | 1M | 1M | 1M | 1M | 1M | 1M | 1M | — |
| −11M |